CPRI holder plans sale of 10,000 shares valued at $259.61K

A shareholder of CPRI has filed a notice to sell 10,000 shares of the company’s common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of 259,610.00.

Rhea-AI Filing Summary

A shareholder of CPRI has filed a notice to sell 10,000 shares of the company’s common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of 259,610.00. The planned sale date is listed as 12/09/2025. The shares were acquired as restricted stock vesting under a registered plan from the issuer between 06/17/2022 and 06/15/2025 in several service-based vesting events.

The table notes that 119,143,278 shares of this class of stock were outstanding, which serves as a baseline for the company’s equity. The person signing the notice represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CPRI shares are planned to be sold under this Form 144 notice?

The notice covers the planned sale of 10,000 shares of CPRI common stock, with an indicated aggregate market value of 259,610.00.

On which exchange and through which broker will the CPRI shares be sold?

The shares are to be sold on the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services, listed at 1 New York Plaza, 8th Floor, New York, NY 10004.

When were the CPRI shares being sold originally acquired?

The shares were acquired as restricted stock vesting under a registered plan from the issuer on various dates, including 06/17/2022, 06/17/2023, 06/15/2023, 06/15/2024, and 06/15/2025, in exchange for services rendered.

What does the Form 144 representation say about undisclosed information at CPRI?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

How many CPRI common shares were outstanding according to this notice?

The securities information section lists 119,143,278 shares of CPRI common stock as outstanding, providing a baseline figure for the company’s equity.

Does this CPRI Form 144 relate to gifted shares?

No. The table shows the shares were acquired through restricted stock vesting under a registered plan from the issuer for services rendered, and the gift field is left blank for each entry.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/09/2025 - 04:13 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002074060
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CAPRI HOLDINGS LIMITED
SEC File Number	001-35368
Address of Issuer	90 WHITFIELD STREET 2ND FLOOR LONDON UNITED KINGDOM W1T4EZ
Phone	44 207 632 8600)
Name of Person for Whose Account the Securities are To Be Sold	RAJAL MEHTA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	259610.00	119143278	12/09/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/15/2023	Restricted stock vesting under a registered plan	Issuer			3657	06/15/2023	Services Rendered
Common	06/17/2022	Restricted stock vesting under a registered plan	Issuer			500	06/17/2022	Services Rendered
Common	06/15/2024	Restricted stock vesting under a registered plan	Issuer			4141	06/15/2024	Services Rendered
Common	06/17/2023	Restricted stock vesting under a registered plan	Issuer			579	06/17/2023	Services Rendered
Common	06/15/2025	Restricted stock vesting under a registered plan	Issuer			1123	06/15/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Rajal Mehta
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)